Compare HP & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HP | STVN |
|---|---|---|
| Founded | 1920 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Containers/Packaging |
| Sector | Energy | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 1994 | 2021 |
| Metric | HP | STVN |
|---|---|---|
| Price | $35.08 | $15.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $34.17 | $25.67 |
| AVG Volume (30 Days) | ★ 1.2M | 619.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.90% | 0.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,746,013,000.00 | N/A |
| Revenue This Year | $9.48 | $9.67 |
| Revenue Next Year | $3.00 | $9.99 |
| P/E Ratio | ★ N/A | $27.15 |
| Revenue Growth | ★ 35.89 | N/A |
| 52 Week Low | $14.65 | $12.89 |
| 52 Week High | $37.87 | $28.00 |
| Indicator | HP | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 55.75 |
| Support Level | $32.93 | $14.23 |
| Resistance Level | $36.35 | $16.69 |
| Average True Range (ATR) | 1.25 | 0.59 |
| MACD | -0.16 | 0.20 |
| Stochastic Oscillator | 37.36 | 86.90 |
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.